ZURA Share Price Performance
US$5.38
3.36 (166.34%)
Price US$5.38
Share Pricen/a
Analysis Article • Jun 30
Zura Bio Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
ZURA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Zura Bio Limited Key Details
About ZURA
- Founded
- 2022
- Employees
- 40
- CEO
- WebsiteView website
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
